An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin
Status:
Unknown status
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to assess the continued efficacy of Omacor
co-administered with simvastatin for lowering non-high-density lipoprotein cholesterol
(non-HCL-C) levels.